Axonics, Inc., a leading innovator in the medical device industry, is headquartered in the United States. Founded in 2013, the company has rapidly established itself as a key player in the development of advanced neuromodulation therapies, particularly for bladder and bowel control. Axonics is renowned for its unique sacral neuromodulation systems, which offer patients a minimally invasive solution for managing overactive bladder and faecal incontinence. The company’s flagship product, the Axonics Sacral Neuromodulation System, stands out for its rechargeable technology, providing longer-lasting performance compared to traditional devices. With a strong market position and a commitment to improving patient outcomes, Axonics has achieved significant milestones, including FDA approvals and expanding its operational reach across North America and Europe. The company continues to drive innovation in the field, enhancing the quality of life for countless individuals.
We don't have data for Axonics, Inc., but we can show you information about their parent organization instead.
View parent company